Organoid Cryopreservation Solution: A Key Technology for Safeguarding the Value of 3D Life Models

From single cells to complex 3D structures, organoid cryopreservation medium suspends time at low temperatures and ensures the continuity of scientific research.

Organoid technology has become an essential tool in modern biomedical research, which can simulate the structure and functions of human organs in vitro. However, organoids feature long culture cycles and high costs. How to effectively preserve these valuable 3D biological models has become a key challenge for laboratories.

Specially formulated organoid cryopreservation medium solves this problem via optimized recipes and cryopreservation protocols, supporting the establishment of biobanks and consistent research progress.

01 Organoid Technology and Cryopreservation Challenges

Organoids are in vitro 3D cell aggregates derived from primary tissues or stem cells, capable of self-renewal, self-organization and performing organ-specific functions. These miniature organ models recapitulate the composition and structure of native tissues, overcoming the limitations of traditional 2D culture systems.

Compared with other model systems, organoids are biologically closer to in vivo conditions, making them invaluable tools for disease research, drug screening and personalized medicine.

Nevertheless, long culture duration and high costs greatly restrict their application in biomedical research. This issue is particularly prominent for brain organoids and other types requiring months of continuous cultivation.

Conventional cell cryopreservation methods face severe drawbacks when applied to organoids: low survival rate after freezing and thawing, and failure to maintain the complex structure and functional activity of organoids.

02 Core Components of Organoid Cryopreservation Medium

Organoid cryopreservation medium is a specially optimized cryoprotective solution designed to maintain high viability and functional integrity of organoids during freezing and recovery. Different from regular cell freezing medium, its formula is tailored for the 3D structural characteristics and diverse cell types of organoids.

Basic Components

A typical organoid cryopreservation medium consists of multiple key ingredients, each playing a unique role:

Cryoprotectants are core components that primarily prevent cellular damage caused by ice crystal formation. Dimethyl sulfoxide (DMSO) is the most commonly used agent, which penetrates cell membranes and lowers the freezing point.

Some novel media adopt alternative or auxiliary cryoprotectants such as ethylene glycol.

Osmoprotectants including sucrose, trehalose and glucose stabilize cell membrane structure by regulating osmotic pressure and reduce damage from volume changes during freezing.

Structure & Function Protectants

To meet the specific requirements of organoids, the medium is supplemented with the following functional ingredients:

Extracellular matrix protectants such as methylcellulose and polyvinylpyrrolidone (PVP) are critical for preserving the 3D structural integrity of organoids.

These substances protect intercellular junctions and matrix architecture throughout the freezing process.

Apoptosis inhibitors, represented by the ROCK inhibitor Y27632, markedly reduce programmed cell death during cryopreservation and improve post-thaw survival rate.

03 Technical Principles of Cryopreservation Medium

The working mechanism of organoid cryopreservation medium is based on cryobiology, which protects organoid integrity during freezing and thawing via multiple pathways.

Ice Crystal Control Mechanism

Intracellular and extracellular ice crystal formation is the major cause of cellular damage during freezing. The cryoprotectants in the medium interact with water molecules through hydrogen bonds to lower the freezing point and suppress ice crystal nucleation and growth.

In particular, DMSO remodels water crystal structures to form smaller and more regular ice crystals, alleviating mechanical damage to cell membranes.

Membrane Stabilization Mechanism

Trehalose and sucrose in the medium form amorphous glassy state rather than crystals outside cells during vitrification, which stabilizes the phospholipid bilayer and prevents phase transition.

Meanwhile, these substances act as osmotic buffers to mitigate cell shrinkage caused by water loss during freezing and swelling stress during recovery.

Structure Maintenance Mechanism

For complex 3D organoids, macromolecular polymers such as methylcellulose and PVP in the medium form a protective network around cells to preserve microarchitecture.

For complex models like neural organoids, specialized formulas such as the MEDY formulation (Methylcellulose, Ethylene glycol, DMSO and Y27632) inhibit endoplasmic reticulum-mediated apoptosis and protect synaptic functions.

04 Practical Applications

Organoid cryopreservation medium has a wide range of applications spanning basic research and clinical translation.

Biobank Establishment

With cryopreservation medium, researchers can build disease-specific organoid biobanks, including models for cancer, genetic disorders and neurological diseases. For instance, patient-derived brain organoids for epilepsy retain pathological features after cryopreservation, providing valuable research resources.

Cryopreservation enables large-scale organoid storage, greatly cutting down the time and cost of preparing neural organoids and facilitating bulk preservation of neural organoids and living brain tissues.

Drug Screening & Evaluation

In drug development, frozen organoids are applied for high-throughput drug screening and provide abundant experimental materials with consistent genetic backgrounds. Pharmaceutical companies utilize organoid biobanks to assess drug efficacy and toxicity, improving the predictive value of preclinical studies.

Regenerative Medicine Research

Organoid cryopreservation technology supports cell therapy and tissue engineering. For example, cryopreserved stem cell organoids maintain multipotent differentiation potential for future transplantation therapy.

Studies have confirmed that hydrogel microencapsulation allows mesenchymal stem cells to be cryopreserved with low-dose DMSO (2.5%), keeping cell survival rate above the clinical threshold of 70% and retaining multi-lineage differentiation capacity.

Personalized Medicine

In personalized medicine, cryopreservation medium makes it feasible to establish patient-specific organoid biobanks. These organoids can be thawed on demand to test individual drug responses and achieve truly personalized treatment.

05 Standard Cryopreservation & Recovery Protocols

Standard organoid freezing and thawing procedures include multiple critical steps, and all conditions must be strictly controlled to obtain optimal results.

Pre-freezing Preparation

Select healthy and well-grown organoids for cryopreservation. For compact organoids with multilayered epithelium or squamous cell composition, mild digestion with organoid dissociation solution is recommended before freezing.

Place the freezing container at room temperature or 4°C in advance to ensure controlled cooling.

Organoid Harvesting

Add appropriate basal medium to the culture plate. Gently detach organoids using a cell scraper or pipette tip, and transfer the suspension into centrifuge tubes.

Centrifuge at 150-300 g for 3 minutes and discard the supernatant to collect organoid pellets. Excessively high centrifugal force will cause mechanical damage to organoids.

Resuspension in Cryopreservation Medium

Resuspend the organoid pellets with pre-chilled organoid cryopreservation medium, and adjust cell density to 1×10³–1×10⁷ cells/mL.

Too low density hinders regrowth after thawing, while overly high density weakens the protective effect. Aliquot the mixed suspension into cryovials with a volume no less than 0.5 mL per vial.

Controlled Freezing

Place cryovials into a programmable freezing container, then transfer the container to a -80°C freezer. A well-controlled cooling rate is essential for organoid viability, typically set at -1°C per minute.

After 12–24 hours, transfer the cryovials to liquid nitrogen for long-term storage.

Thawing Protocol

Thaw the cryovial rapidly in a 37°C water bath. Stop heating immediately when only a small amount of ice residue remains.

Transfer the thawed suspension to a centrifuge tube, then slowly add 5–10 volumes of pre-warmed complete medium and mix gently.

Centrifuge at 150-300 g for 3 minutes to wash organoids, and repeat the washing step to fully remove cryoprotectants. Finally, resuspend the pellets with complete medium for subsequent culture.

06 Technical Progress & Future Perspectives

Organoid cryopreservation technology has achieved remarkable advances in recent years, solving previous technical limitations step by step.

Development of Novel Cryopreservation Formulas

The MEDY technology developed by Fudan University represents a major breakthrough for neural organoid cryopreservation. This formula contains 1% methylcellulose, 10% ethylene glycol, 10% DMSO and 10 μM Y27632, which effectively protects the complex structure and functions of brain organoids.

Studies demonstrate that cortical organoids frozen with MEDY fully retain functional and structural integrity after 21 days and 50 days of post-thaw culture. Even after 1.5 years of cryostorage, progenitor cells and neurons remain in good condition.

DMSO Reduction & Substitution Strategies

Reducing DMSO dosage is a key research direction. Scientists are exploring low-DMSO or DMSO-free cryopreservation protocols to reduce potential toxicity.

For example, hydrogel microencapsulation enables effective cryopreservation of mesenchymal stem cells with DMSO concentration as low as 2.5%, while maintaining cell survival rate above the 70% clinical threshold.

Likewise, in platelet cryopreservation, the combination of controlled rate freezing (CRF) and deep eutectic solvents (DES) realizes DMSO-free platelet preservation.

Function Preservation Technology

State-of-the-art cryopreservation techniques focus not only on cell viability but also on the maintenance of functional integrity. Optimized protocols allow thawed organoids to preserve neuronal electrophysiological activity and intercellular junctions, which are essential for neuroscience research.

Single-cell transcriptome analysis confirms that optimized cryopreservation will not significantly alter the gene expression profiles and cell type proportions of organoids, ensuring reliable experimental results.

With continuous technological innovation, organoid cryopreservation medium is evolving toward higher specialization and refinement. Organoids derived from different tissues may require customized formulas, and the integration of automated cryopreservation systems will improve experimental reproducibility.

In the future, more standardized organoid cryopreservation protocols will enable global laboratories to share organoid resources and accelerate the progress of biomedical research.

Contact Absin

Absin provides antibodies, proteins, ELISA kits, cell culture, detection kits, and other research reagents. If you have any product needs, please contact us.

Absin Bioscience Inc. worldwide@absin.cn

Follow us on Facebook: Absin Bio